TRACON Pharmaceuticals, Inc. announced that Patricia L. Bitar resigned from her position as the Chief Financial Officer of company, effective June 15, 2018. Effective upon Ms. Bitar's resignation, Charles P. Theuer, M.D., Ph.D., the Company's Chief Executive Officer, was appointed as the Company's principal financial officer and principal accounting officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | +2.40% | -14.09% | -63.45% |
05-14 | TRACON Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-14 | Transcript : TRACON Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.45% | 2.91M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- TCON Stock
- News TRACON Pharmaceuticals, Inc.
- Tracon Pharmaceuticals, Inc. Announces Executive Changes